Join the thousands of professionals, journalists, government leaders, law firms, associations, and others who turn to EIN News for complete news coverage.
Commercial Insight - Osteoporosis - Risk management and reformulation offer best defense against generic onslaught2 Jul 2008 08:13 GMT ... a major upheaval when market leader Fosamax (alendronate) loses its US patent. The resultant heightened ... the osteoporosis market across the seven major pharmaceutical markets Future market events that are expected ... market events that are expected to affect drug revenues are discussed and quantified for each of ...
Do you want to reach readers of Arizona politics? Zimbabwe agriculture? A to Z we have you covered.
For less than a dollar a day, place your ad on the exact pages that will do you the most good.
Try our 7 day free trial.